You just read:

Orexigen Therapeutics Announces Commercialization and Distributorship Agreement with Valeant for Contrave® (naltrexone HCl / bupropion HCl extended release) in Australia and New Zealand

News provided by

Orexigen Therapeutics, Inc.

Nov 08, 2016, 07:30 ET